aUniversity of Toronto, Toronto, Canada
bVeterans Medical Research Foundation, San Diego and University of California, San Diego, California, USA
cDepartment of Addiction Science, Taipei City Psychiatric Center, Taipei, Taiwan
dCentre for Addiction Mental Health and Department of Pharmacology, Toronto, Canada
Sponsorship: CIHR MOP-53248, The Center for Addiction and Mental Health and California Tobacco Related Disease Research Program grants 10RT-0142 and 12RT-0004, supported this study. J.C.M. receives funding from CIHR-STPTR, T.L.W. receives funding from NIH K02 AA00269, and R.F.T. holds a Canadian Research Chair in Pharmacogenetics.
Correspondence and requests for reprints to Rachel F. Tyndale, Room 4326 Medical Sciences Building, 1 King's College Circle, University of Toronto, Toronto, Ontario M5S 1A8, Canada
E-mail: [email protected]
Received 21 October 2004 Accepted 4 January 2005